FAMILIAL ALZHEIMER'S DISEASE NEUROPROGENITOR CELLS DISPLAY PRONOUNCED MITOCHONDRIAL METABOLISM ALTERATIONS (ID 2236)

Presenter
Authors
Gallery Display
Onsite Oral and Gallery PDF
Audio MP3

Audio MP3

Hide

Previous ePoster
MITOCHONDRIAL DEFECTS IN ALZHEIMER’S DISEASE: MECHANISMS AND THERAPEUTIC APPROACHES (ID 2235)

Next ePosters
OXIDATIVE STRESS TRIGGERS BASAL FOREBRAIN NEURODEGENERATION BY IMPAIRING PRONGF AXONAL TRANSPORT (ID 2237)
INVOLVEMENT OF RNA MODIFICATIONS AND CORRESPONDING WRITER ENZYMES AT A SPECIFIC MITOCHONDRIAL MRNA SITE IN ALZHEIMER'S DISEASE (ID 2239)
NEURONS ISOLATED FROM A53T SYNUCLEIN MICE DISPLAY DEFICITS IN SYNAPTIC DENISTY AND MITOCHONDRIAL FUNCTION THAT CAN BE ATTENUATED BY NRF2 ACTIVATION (ID 2240)
THE TRANSCRIPTOMIC LANDSCAPE OF ALZHEIMER'S DISEASE REVEALS DYSREGULATED MITOCHONDRIAL-RELATED PATHWAYS (ID 2241)
LOSS OF WWOX AND MUTATIONS IN THE GENE CONTRIBUTE TO MITOCHONDRIAL DYSFUNCTION IN AMYOTROPHIC LATERAL SCLEROSIS (ID 2242)
LOAD2: A NOVEL MOUSE MODEL FOR INVESTIGATING INTERACTIONS BETWEEN GENETIC AND ENVIRONMENTAL RISK FACTORS FOR LATE-ONSET ALZHEIMER'S DISEASE (ID 2244)
SIRT6 ROLES IN PROTECTING THE BRAIN FROM NEURODEGENERATION (ID 2247)
PM20D1-DERIVED TREATMENT DECREASES AMYLOID PATHOLOGY AND IMPROVES COGNITIVE PERFORMANCE IN C.ELEGANS AND MOUSE MODELS OF ALZHEIMER´S DISEASE (ID 2248)
THE ROLE OF LIPID BINDING OF ALPHA-SYNUCLEIN IN LEWY BODY FORMATION (ID 2250)
THE ASSOCIATIONS OF Α-SYNUCLEIN WITH PHOSPHOINOSITIDES PROVIDE CLUES TO CRITICAL QUESTIONS RELATED TO ITS PATHOPHYSIOLOGY IN PARKINSON’S DISEASE. (ID 2251)